Cargando…

The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications

Endocytosis is one of the major ways cells communicate with their environment. This process is frequently hijacked by pathogens. Endocytosis also participates in the oncogenic transformation. Here, we review the approaches to inhibit endocytosis, discuss chemical inhibitors of this process, and disc...

Descripción completa

Detalles Bibliográficos
Autores principales: Szewczyk-Roszczenko, Olga Klaudia, Roszczenko, Piotr, Shmakova, Anna, Finiuk, Nataliya, Holota, Serhii, Lesyk, Roman, Bielawska, Anna, Vassetzky, Yegor, Bielawski, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527932/
https://www.ncbi.nlm.nih.gov/pubmed/37759535
http://dx.doi.org/10.3390/cells12182312
_version_ 1785111208730296320
author Szewczyk-Roszczenko, Olga Klaudia
Roszczenko, Piotr
Shmakova, Anna
Finiuk, Nataliya
Holota, Serhii
Lesyk, Roman
Bielawska, Anna
Vassetzky, Yegor
Bielawski, Krzysztof
author_facet Szewczyk-Roszczenko, Olga Klaudia
Roszczenko, Piotr
Shmakova, Anna
Finiuk, Nataliya
Holota, Serhii
Lesyk, Roman
Bielawska, Anna
Vassetzky, Yegor
Bielawski, Krzysztof
author_sort Szewczyk-Roszczenko, Olga Klaudia
collection PubMed
description Endocytosis is one of the major ways cells communicate with their environment. This process is frequently hijacked by pathogens. Endocytosis also participates in the oncogenic transformation. Here, we review the approaches to inhibit endocytosis, discuss chemical inhibitors of this process, and discuss potential clinical applications of the endocytosis inhibitors.
format Online
Article
Text
id pubmed-10527932
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105279322023-09-28 The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications Szewczyk-Roszczenko, Olga Klaudia Roszczenko, Piotr Shmakova, Anna Finiuk, Nataliya Holota, Serhii Lesyk, Roman Bielawska, Anna Vassetzky, Yegor Bielawski, Krzysztof Cells Review Endocytosis is one of the major ways cells communicate with their environment. This process is frequently hijacked by pathogens. Endocytosis also participates in the oncogenic transformation. Here, we review the approaches to inhibit endocytosis, discuss chemical inhibitors of this process, and discuss potential clinical applications of the endocytosis inhibitors. MDPI 2023-09-19 /pmc/articles/PMC10527932/ /pubmed/37759535 http://dx.doi.org/10.3390/cells12182312 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Szewczyk-Roszczenko, Olga Klaudia
Roszczenko, Piotr
Shmakova, Anna
Finiuk, Nataliya
Holota, Serhii
Lesyk, Roman
Bielawska, Anna
Vassetzky, Yegor
Bielawski, Krzysztof
The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications
title The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications
title_full The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications
title_fullStr The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications
title_full_unstemmed The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications
title_short The Chemical Inhibitors of Endocytosis: From Mechanisms to Potential Clinical Applications
title_sort chemical inhibitors of endocytosis: from mechanisms to potential clinical applications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527932/
https://www.ncbi.nlm.nih.gov/pubmed/37759535
http://dx.doi.org/10.3390/cells12182312
work_keys_str_mv AT szewczykroszczenkoolgaklaudia thechemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT roszczenkopiotr thechemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT shmakovaanna thechemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT finiuknataliya thechemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT holotaserhii thechemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT lesykroman thechemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT bielawskaanna thechemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT vassetzkyyegor thechemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT bielawskikrzysztof thechemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT szewczykroszczenkoolgaklaudia chemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT roszczenkopiotr chemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT shmakovaanna chemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT finiuknataliya chemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT holotaserhii chemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT lesykroman chemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT bielawskaanna chemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT vassetzkyyegor chemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications
AT bielawskikrzysztof chemicalinhibitorsofendocytosisfrommechanismstopotentialclinicalapplications